CCR2 and focal segmental glomerulosclerosis: In conclusion, we have utilized two murine models that recapitulate key aspects of FSGS and show that selective CCR2 inhibition results in rapid and profound decreases in proteinuria and improvements in renal function measured by creatinine and BUN.